Aging Population and Promising Pipeline Drugs Drives the Global Acute Heart ... San Francisco Chronicle In the US, AHF represents a small portion of the overall heart failure market and over the years pharma companies have found AHF market to be less attractive, due to the presence of a lesser number of patient population. [...] over the past few decades ... |
